XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Preferred Shares
Common Shares
Additional Paid-in-Capital
Accumulated Distributions in Excess of Net Income
Accumulated Other Comprehensive Income/(Loss)
Noncontrolling Interests
Beginning balance at Dec. 31, 2022 $ 2,391,003 $ 94,016 $ 29 $ 3,320,087 $ (1,079,087) $ 17,689 $ 38,269
Beginning balance (in shares) at Dec. 31, 2022   1,935,400 291,719,310        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of partnership interest in real estate 106           106
Issuance of common shares and deferred compensation amortization, net 2,156     2,156      
Issuance of common shares and deferred compensation amortization, net (in shares)     1,216,166        
Repurchase of common shares to settle tax obligations (2,076)     (2,076)      
Repurchase of common shares to settle tax obligations (in shares)     (204,780)        
Redemption of noncontrolling OP units for common shares 0     18     (18)
Redemption of noncontrolling OP units for common shares (in shares)     3,572        
Forfeiture of employee common shares (in shares)     (176,547)        
Dividends/distributions (38,222)       (37,954)   (268)
Net income (loss) 11,315       11,166   149
Other comprehensive income (loss) (3,190)         (3,190)  
Company's share of other comprehensive income (loss) of non-consolidated entities (330)         (330)  
Ending balance at Mar. 31, 2023 2,360,762 $ 94,016 $ 29 3,320,185 (1,105,875) 14,169 38,238
Ending balance (in shares) at Mar. 31, 2023   1,935,400 292,557,721        
Beginning balance at Dec. 31, 2023 2,265,457 $ 94,016 $ 29 3,330,383 (1,201,824) 9,483 33,370
Beginning balance (in shares) at Dec. 31, 2023   1,935,400 293,449,088        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of partnership interest in real estate 464           464
Issuance of common shares and deferred compensation amortization, net 2,283     2,283      
Issuance of common shares and deferred compensation amortization, net (in shares)     1,446,693        
Repurchase of common shares to settle tax obligations (1,588)     (1,588)      
Repurchase of common shares to settle tax obligations (in shares)     (160,079)        
Purchase of noncontrolling interest in consolidated joint venture (4,910)     (3,396)     (1,514)
Forfeiture of employee common shares (in shares)     (446,133)        
Dividends/distributions (39,577)       (39,502)   (75)
Net income (loss) (555)       (269)   (286)
Other comprehensive income (loss) (1,101)         (1,101)  
Company's share of other comprehensive income (loss) of non-consolidated entities 41         41  
Ending balance at Mar. 31, 2024 $ 2,220,514 $ 94,016 $ 29 $ 3,327,682 $ (1,241,595) $ 8,423 $ 31,959
Ending balance (in shares) at Mar. 31, 2024   1,935,400 294,289,569